Eltek Ltd. — FY2016 Form 20-F Summary
Reporting period: Fiscal year ended December 31, 2016. This is an annual report, not a standalone fourth-quarter filing. Financial statements are prepared under U.S. GAAP and presented in U.S. dollars; amounts below are in millions unless stated otherwise.
Business context
Eltek manufactures custom, technologically advanced printed circuit boards, including high-density interconnect and flex-rigid boards, primarily for defense and aerospace, medical, industrial, telecommunications, and electronics-manufacturing customers. Its production facilities are in Israel, with sales subsidiaries in the United States and Germany. In December 2016, Eltek sold its interest in German PCB manufacturer Kubatronik.
Financial performance and position
| Metric | FY2016 | FY2015 |
|---|---|---|
| Revenue | $37.065 | $41.350 |
| Gross profit / margin | $2.817 / 7.6% | $6.548 / 15.8% |
| Operating income (loss) | ($1.999) | $1.497 |
| Net income (loss) | ($3.725) | $1.026 |
| Net income (loss) attributable to Eltek shareholders | ($3.624) | $1.043 |
| Basic and diluted earnings (loss) per share | ($0.36) | $0.10 |
| Cash from operating activities | $0.165 | $1.720 |
| Cash and cash equivalents at year-end | $1.234 | $1.038 |
| Total assets | $20.145 | $25.419 |
| Shareholders’ equity | $6.634 | $10.335 |
Cash used in investing activities was $0.750 million, mainly for fixed assets and intangible assets; cash provided by financing activities was $0.473 million. Year-end current assets were $11.320 million and current liabilities were $11.413 million, implying a $93,000 working-capital deficit. The filing’s liquidity discussion separately states a $29,000 deficit, so the reported values do not agree.
At year-end, the balance sheet reported $2.868 million of short-term credit and current maturities of long-term debt, plus $1.954 million of long-term debt excluding current maturities. Bank facilities were secured by company assets. The company was out of compliance with its debt-service covenant but received a bank waiver for 2016. The filing also reports $2.9 million of long-term loans including supplier credit; debt figures should be reconciled against the notes and contractual-obligations table.
Changes versus the prior year
- Revenue declined 10.4%, primarily because of weaker demand, particularly from military customers. Revenue had also declined in 2015 and 2014.
- Cost of revenue fell only 1.6%, less than the revenue decline. Management attributed the resulting gross-margin contraction to fixed costs that could not be reduced sufficiently.
- SG&A decreased 5.3% to $4.699 million, reflecting cost-cutting and lower sales commissions; this was insufficient to offset lower gross profit.
- Operating results shifted from $1.497 million of income to a $1.999 million loss. The net loss also included a $1.158 million tax expense, primarily from writing off deferred tax assets, and a $259,000 net other loss associated primarily with the Kubatronik sale.
- Operating cash flow fell to $165,000 from $1.720 million. Working-capital movements, including lower receivables and inventory, helped cash generation despite the net loss.
- Backlog declined to approximately $4.5 million from $6.5 million; orders may be cancelled and backlog is not necessarily indicative of future sales.
Outlook, risks, contingencies, and unusual items
- Management expected approximately $600,000 of 2017 capital expenditures, mainly for Israeli manufacturing equipment and capacity and technology upgrades. It planned to use operating cash flow, bank loans, and supplier credit, while warning financing might not be available on acceptable terms. Management expected available resources to cover liquidity needs through 2017, subject to demand, exchange rates, and other operating factors.
- Eltek cited reduced demand, customer purchasing shifts, competition and price pressure, manufacturing challenges, and NIS currency movements as risks to future profitability. A 1% weakening of the U.S. dollar against the NIS was estimated to reduce operating income by approximately $205,000. Eltek was not then engaged in hedging transactions.
- In the Kubatronik disposal, Eltek paid the former minority shareholder €483,000, advanced and forgave €110,000, and forgave Kubatronik debt of approximately €1.031 million. Eltek recognized a $271,000 loss and may receive contingent payments tied to Kubatronik profits in 2017–2019.
- Environmental matters include a July 2016 settlement with Meitav for NIS 200,000 (about $50,000), following demands totaling NIS 3.8 million (about $980,000) excluding VAT. Six wastewater samples in 2016 met applicable standards. An emissions permit and a new business permit remained pending; the company disclosed potential fines and factory-shutdown risk if it cannot meet permit conditions.
- Four former employees sought approximately $1.0 million in employment-related claims; the company recorded a provision based on legal advice. Other employee injury claims were also disclosed, with insurance coverage still under review. A software supplier’s potential intellectual-property claim had no clear estimated exposure in the filing.
- Nasdaq notified Eltek in December 2016 that its share price did not meet the $1.00 minimum bid requirement; the stated deadline to regain compliance was June 26, 2017. The 2016 year-end closing price was $0.79.
- One affiliated customer group represented 16.3% of 2016 revenue, down from 17.9% in 2015. One supplier accounted for 22.4% of raw-material costs. The company also identified financing needs, customer concentration, raw-material sourcing, environmental compliance, and competition from lower-cost Asian manufacturers as risks.
- No cash dividends had been paid, and management did not expect dividends in the foreseeable future. The auditor issued an unmodified opinion on the financial statements. Management reported effective disclosure controls and effective internal control over financial reporting; the auditor did not audit internal control effectiveness.
Important facts for investors to verify
- Reconcile the filing’s conflicting working-capital deficits ($93,000 in the balance-sheet data versus $29,000 in the liquidity discussion) and confirm the complete debt balance and maturity presentation.
- Confirm current covenant status, the scope and duration of bank waivers, and continued access to revolving credit and supplier financing.
- Track sales, gross-margin recovery, backlog conversion, and military-customer demand, especially given the continued revenue decline and fixed-cost sensitivity.
- Verify issuance of the emissions permit and new business permit, compliance costs, and the resolution or financial exposure of disclosed environmental and employee claims.
- Assess the impact of the Kubatronik sale, including the debt forgiveness, recognized loss, ongoing commercial arrangements, and contingent consideration.
- Monitor Nasdaq bid-price compliance and any effect on listing status, trading liquidity, or potential corrective actions.